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Casimiroa edulis is known as cochitzapotl, and it belongs a species of tropical 23 
fruiting tree in the family Rutaceae, native to eastern Mexico and Central America south 24 
to Costa Rica. In this study, we isolated two furocoumarins and two 25 
polymethoxyflavones from leaves of Casimiroa edulis and evaluated the functions of 26 
glucose and lipid metabolism activity with 3T3-L1 adipocytes. We discovered that the 27 
addition of furocoumarins increased glucose uptake and lipid accumulation in 3T3-L1 28 
 2 
adipocyte. These results suggest that furocoumarin compounds can be used as 1 
functional food-derived compounds, to regulate adipocyte functioning for the 2 
management of metabolic syndrome, which is associated with dysfunctions of glucose 3 
and lipid metabolism. 4 
 5 
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Casimiroa edulis is a species of tropical fruiting tree. Zapotin in Casimiroa edulis 14 
has been found to induce both cell differentiation and apoptosis in cultured human 15 
promyelocytic leukemia HL-60 cells.
1)
 This compound inhibits 16 
12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ornithine decarboxylase (ODC) 17 
activity in human bladder carcinoma cells (T24 cells) and TPA-induced nuclear 18 
factor-kappa B (NF-κB) activity in human hepatocellular liver carcinoma cells (HepG2 19 
cells).
2)
 The data suggest that zapotin deserves further investigation as a potential cancer 20 
suppressive agent. Crude plant extracts of seeds and of leaves of Casimiroa edulis have 21 
been found to affect blood pressure, cardiac activity,
3-5)
 and aortic muscular tone,
6)
 and 22 
to possess anticonvulsant activity,
7,8)
 but previous study has focused mainly on seed 23 
components and leaf components that were not studied well.  24 
Adipocytes play a major role in the maintenance of energy balance. The amount 25 
of glucose uptake into the adipocytes is significant in the maintenance of serum glucose 26 
levels, because adipocyte-specific knock-out of an insulin-dependent glucose 27 
transporter (glut4) results in diabetic symptoms.
9)
 Lipid synthesis (lipogenesis) is also a 28 
 3 
vital function of adipocytes. In vivo studies have suggested that adipose tissue is 1 
responsible for more than 50% of fatty acid synthesis in mammals.
10)
 Fatty acid (FA) 2 
synthesis is a cytosolic process utilizing acetyl CoA as precursor. It is generally 3 
accepted that fatty acid is synthesized from various substrates (glucose, pyruvate, lactate 4 
and acetate).
11)
 It is indispensable for the management of adipocyte functions to 5 
evaluate complicated metabolisms, including lipogenesis and glucose uptake.  6 
In this study, we tried to isolate phenolic compounds from Casimiroa edulis 7 
leaves, and investigated other effect, adipogenesis, including glucose uptake, fatty acid 8 
synthesis activity, and lipid accumulation with 3T3-L1 adipocytes. PPARγ synthesized 9 
ligand, pioglitazone, was used as positive control, since PPARγ is abundantly expressed 10 
in 3T3-L1 adipocytes and plays a central role in metabolism and differentiation.
12)
 11 
Pioglitazone, a major insulin sensitizer, promotes preadipocyte metabolism including 12 
glucose uptake and FA synthesis through PPARγ activation 13) and is widely used in the 13 






Materials and Methods 20 
Leaves of Casimiroa edulis were collected at the Botanical Garden of Nippon 21 
Shinyaku Co., Kyoto, Japan. The voucher specimen was deposited at Gifu 22 
Pharmaceutical University. 
13
C6 glucose and pioglitazone was purchased from Sigma 23 
(St. Louis, MO). [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16-
13
C] palmitic acid was from 24 
Watari (Tokyo). Unless otherwise indicated, all chemicals were purchased from Nacalai 25 
Tesque (Kyoto, Japan) or Wako Pure Chemicals (Osaka, Japan) and were of guaranteed 26 
reagent grade or tissue culture grade.  27 
 28 
 4 




C-NMR spectra were recorded on an 1 
EX400 (
1
H at 400 MHz and 
13
C at 100 MHz, JEOL) spectrometer. Chemical shifts 2 
appeared as  values with trimethylsilane (TMS) as internal reference. Peak 3 
multiplicities were quoted in Hz. EI-MS was recorded on a JMSDX-300 (JOEL) 4 
spectrometer. Kiesel gel 60 (60-230 mesh, Merck, Japan) and Fuji Silysia Chemical 5 
Chromatorex ODS (100—200 mesh) were used for column chromatography. Kiesel-gel 6 
60 F256 (Merck, Tokyo) at 0.25 mm was used for analytical and 0.5 mm for preparative 7 
TLC. 8 
 9 
Extraction and isolation of compounds. Dried leaves (550 g) extracted with 10 
MeOH (1 L x 5 times) at room temperature and was evaporated in vacuo. The MeOH 11 
extract (52 g) obtained was chromatographed on Silica gel (250 mm × 30 mm) with a 12 
mixture of chloroform –MeOH by increasing the polarity from 0% to 10 % methanol. 13 
The chloroform-MeOH (10:1) (3.5g) was further chromatographed on an ODS column 14 
(250 mm × 20 mm) eluted with H2O, followed by increasing the concentration of 15 
MeOH to give four fractions. Fraction 2 (263 mg, 70% methanol) was repeatedly 16 
purified by preparative TLC (n-hexane-EtOAc 1:4) to give 1 (5 mg), 2 (7 mg), 3 (12 17 
mg), and 4 (10 mg). 18 
 19 
8-(3'-Hydroxymethyl-but-2-enyloxy)-psoralen acetate (compound 1). White 20 
amorphous solid. Negative ion FABMS [M-H]

 m/z 327. 1H NMR(CDCl3) : 1.81 (3H, 21 
br s, H-5'), 2.04 (3H, s, acetyl-Me), 4.66 (2H, br s, H-4'), 5.09 (2H, br d, J = 7.0 Hz, 22 
H-1'), 5.86 (1H, br t, J = 7.0 Hz, H-3'), 6.38 (1H, d, J = 10.0 Hz, H-4), 6.82 (1H, d, J = 23 
2.5 Hz, H-9), 7.37 (1H, s, H-5), 7.69 (1H, d, J = 2.5 Hz, H-10), 7.77 (1H, d, J = 10.0 Hz, 24 
H-3): 
13
C NMR (CDCl3) : 160.43 (C-2), 114.83 (C-4), 144.27 (C-4), 116.54 (C-4a), 25 
113.81 (C-5), 125.95 (C-6), 148.32 (C-7), 131.39 (C-8), 143.67 (C-8a), 106.76 (C-9), 26 
146.76 (C-10), 69.12 (C-1'), 125.13 (C-2'), 136.57 (C-3'), 62.79 (C-4'), 21.42 (C-5'), 27 
20.83 (acetyl-Me), 170.85 (acetyl C=O). 28 
 5 
 1 
8-(3'-Hydroxymethyl-but-2-enyloxy)-5-methoxypsoralen acetate (compound 2). 2 




H NMR(CDCl3) : 3 
1.80 (3H, s, H-5'), 2.03 (3H, s, acetyl Me), 4.18 (3H, s, C-5 OMe), 4.66 (2H, br s, H-4'), 4 
4.91 (2H, br d, J = 7.0 Hz, H-1'), 5.86 (1H, br t, J = 7.0 Hz, H-2'), 6.28 (1H, d, J = 10.1 5 
Hz, H-3), 6.99 (1H, d, J = 2.5 Hz, H-9), 7.64 (1H, d, J = 2.5 Hz, H-10), 8.12 (1H, d, J = 6 
10.1 Hz, H-4); 
13
C NMR (CDCl3) : 160.42 (C-2), 112.91 (C-3), 139.55 (C-4), 107.61 7 
(C-4a), 144.26 (C-5), 114.61 (C-6), 150.57 (C-7), 136.51 (C-8), 125.63 (C-8a), 105.12 8 
(C-9), 145.16 (C-10), 69.36 (C-1'), 125.27 (C-2'), 136.51 (C-3'), 62.78 (C-4'), 21.41 9 
(C-5'), 20.84 (acetyl Me), 170.84 (acetyl C=O), 60.79 (3H, s, C-5 OMe). 10 
 11 
5,6,2',3',5',6'-Hexamethoxyflavone (compound 3). White amorphous solid: 12 
exhibited spectral data (
1
H NMR and EIMS) comparable to published data.
14)
  13 
 14 
5.6.2'-Trimethoxyflavone (compound 4). White amorphous solid: 
1
H NMR data 15 




C NMR (CDCl3) : 159.05, 157.90 (C-2, C-2'), 16 
111.68 (C-2), 178.41 (C-4), 119.07, 119.02 (C-4a, 8), 147.82 (C-5), 149.65 (C-6), 17 
113.33 (C-7), 151.82 (C-8a), 120.65 (C-1'), 112.96 (C-3'), 132.13 (C-4'), 120.62 (C-5'), 18 
129.07 (C-6') 19 
 20 
LC/MS system. The Agilent Series 1100 LC system (Agilent Technologies, 21 
Waldbronn, Germany) consisting of a G1323B control module, a G1312A quaternary 22 
pump, a G1322 degasser, a G1329A, a G1330A autosampler, a G1316A column oven, 23 
and a G1314A detector, was used. The column used was an Xbridge
TM
 (C18 3.5 μm, 24 
2.1×150 mm, Waters, Milfold, MA). The LC pump gradient was as follows: 85% 25 
mobile phase A (water in 5 mM ammonium acetate) and 15% mobile B (methanol in 5 26 
mM ammonium acetate) from 0 to 20 min, 99% mobile phase A and 1% mobile phase B 27 
from 20 to 20.1 min, and 85% mobile phase A and 15% mobile B from 20.1 to 35 min. 28 
 6 
The injection volume, flow rate, and column temperature were 5 μL, 0.2 mL, and 40°C, 1 
respectively. MS conditions were selected ion monitoring (SIM); polarity negative; 10 2 
psi nebulizer gas, 150 V fragment ion voltage; 3,000 V Capillary voltage, 350°C; dwell 3 
time 50 msec. Unless otherwise specified, all reagents used were of analytical grade, 4 
and the water was deionized. Solvent: LC/MS grade methanol. [1,2,3,4,5,6-
13
C] glucose 5 
and [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16-
13




Spectra of furocoumarins were determined in LC/MS scan mode, polarity 8 
negative (50- 400 m/z). 9 
 10 
GC/MS system. Gas-chromatographic analyses were performed using an Agilent 11 
6890 quadrupole gas chromatograph (GC) equipped with an Agilent 5973B mass 12 
spectrometer (MS). The GC column was a DB-5MS+DG capillary type (30m × 0.25 13 
mm i.d., 0.25μm film thickness; J＆W Scientific, Folsom, CA). A 1-μL extract was 14 
injected in splitless mode at an injection temperature of 250°C. The oven temperature 15 
was programmed to increase from an initial 60°C (held for 1 min) to 300°C (held for 2 16 
min) at a rate of 20°C/min. The temperatures of the quadrupole and ion source were 150 17 
and 230°C. The GC-MS system was operated in scan mode (50-500 m/z) with the 18 
electron multiplier tune value. 19 
 20 
Cell culture. 3T3-L1 preadipocytes, purchased from the American Type Culture 21 
Collection (Rockville, MD), were grown in DMEM-high glucose medium 22 
supplemented with 10% fetal bovine serum, 100 U/mL of penicillin, and 100 μg/mL 23 
streptomycin at 37°C in 5% CO2 using a 12-well plate (5× 104 cell/well). 24 
Post-confluent preadipocytes were differentiated into adipocytes by adding 10 μg/mL 25 
insulin, 0.1 μg/mL dexamethasone, and 112 μg/mL isobutylmethylxanthine to the 26 
medium with 5 μM pioglitazone, and 5 μM each test compound in DMSO, as previously 27 
described.
12)
 The differentiation medium was removed after 2 days and replaced with 28 
 7 
DMEM-high glucose medium containing 5 μg/mL insulin with TZD or the test 1 
compound every 2 days. Ten days after the addition of the differentiation medium, the 2 
cells were plated in culture dishes for a given experiment. After differentiation, they 3 
were washed with warm PBS, and the medium was replaced with glucose-free DMEM 4 
containing 4.5 mg/mL [1,2,3,4,5,6-
13
C] glucose. They were incubated for a further 48 h. 5 
This was repeated twice. 6 
 7 
Extract and saponification. The media were collected after incubation for specific 8 
durations and diluted with methanol. Diluents were filtered with a 0.22 μm filter 9 
membrane, and were analyzed by the LC/MS system. The cells were dissolved in 5 mL 10 
KOH 20% (ethanol:water 4:6; v/v), and hydrolyzed for 60 min at 80°C, followed by 11 
acidification with 6 mL 5 N HCl. The FAs were extracted twice with 4 ml diethylether, 12 
dried under N2 at 40°C, dissolved in 5 ml methanol, and analyzed by the LC/MS 13 
system.  14 
 15 
Oil Red O staining. Cells were fixed with 10% formaldehyde/PBS and stained  16 
with Oil Red O solution (0.5% Oil Red O-isopropyl alcohol/H2O (3:2, v/v)). 17 
 18 
Statistical analysis. Results are expressed as mean and standard error of mean 19 
(SEM). Statistical significance of differences among  groups was evaluated by 20 






Results and Discussion 27 
NMR analysis. The
 1
H NMR of compound 1 showed the presence of two sets of 28 
 8 
coupled protons that  6.38 and 7.77 (J = 10.0 Hz) and  6.82 and 7.69 (J = 2.5 Hz). 1 
The data indicated compound 1 was a furocoumarin. An aromatic singlet ( 7.37) was 2 
also observed that correlated with the C-4 signal of the coumarin skeleton in the HMBC 3 





C NMR showed the presence of two oxymethylene ( 4.66 and 5 
5.09, andC 62.79 and 69.12), a tri-substituted double bond (H 5.09; C 125.13 and 6 
136.57), a methyl attached to a double bond (H 1.81; C 21.41), and an acetyl group (H 7 
2.04; C 20.83 and 170.85). In the HMBC spectrum, an oxymethylene proton was 8 
correlated with C-8 of a coumarin. These data are characteristic of a prenyloxy group, in 9 
which one of methyl groups had been oxidized to a hydroxyl methyl and acetylated. The 10 
hydroxymethyl group was of the cis form with respect to the oxymethylene group (H-1') 11 
of the prenyl substituent on the basis of the NOESY spectrum (H-1'/H-4' and H-2'/H-5'). 12 
Therefore, the structure was determined to be as described in Fig. 1. This compound 13 





H NMR spectrum of compound 2 was very similar to that of 1, but an 15 
aromatic proton disappeared and a methoxy group ( 4.18) was observed. An NOE was 16 
observed between the methoxy group and H-4 of the coumarin skeleton. By detailed 17 
analysis of NMR by 2D methods, the structure of 2 was determined to 5-methoxylated 18 
compound of 1. A deacetylated coumarin of 2 was isolated from Casimiroa tetrameria. 19 
To the best of our knowledge, compound 2 was a new compound. 20 
The structures of compounds 3 and 4 were determined and identified by 21 
comparison to previous data as 5,6,2',3',5',6'-hexamethoxyflavone (3)
18)
 and 22 
5.6.2'-trimethoxyflavone (4)
14,18)
 respectively.  23 
Figure 2 shows spectra of furocoumarins and polymethoxyflavones. Parent ions 24 
of them as determined by NMR were obtained by LC/MS and GC/MS analysis (327, 25 
357, 402, 312 m/ z). This result confirms the NMR analysis data.  26 
 27 
Glucose uptake and glycerol output activity. To elucidate the effects of 28 
 9 
compounds 1-4 on adipocyte functioning, we examined the insulin-dependent glucose 1 
uptake and glycerol output of differentiated 3T3-L1 adipocytes. As shown in Fig. 3A, 2 
the addition of 5 μM compounds 1 and 2 enhanced the insulin-dependent uptake of 3 
glucose (1.2-1.3 fold increases as compared to control). The addition of the other 4 
compounds did not enhance insulin-dependent uptake of glucose. On the other hand, the 5 
addition of 5 μM compounds 1-4 did not enhance glycerol output or lipolysis (Fig. 3B). 6 
These compounds at the concentrations used in this study did not affect cell viability 7 
(data not shown).  8 
 9 
De novo FA synthesis activity and lipid accumulation of adipocytes. To assess the 10 
effects of compounds 1-4 on lipid methabolism in 3T3-L1 adipocytes, we analyzed de 11 
novo FA syntheses activty with compounds 1-4. Figure 3C shows new synthesis of 12 
palmitic acid in 3T3-L1 adipocytes treated with compounds 1-4 for 48 h. The addition 13 
of pioglitazone at (5.0 μM) increased the amounts of synthesized FA, by approximately 14 
2.2-fold in the 3T3-L1 adipocytes as compared with control. The addition of 5.0 μM 15 
conpounds 1 and 2 enhanced FA syntheses by approximately 1.5-fold as compared with 16 
control. Finally, to investigate the dose-dependent effects of furocoumarins on the lipid 17 
accumulation of adipocytes, we performed Oil Red O staining. The addition of 18 
furocoumarins increased lipid accumulation dose-dependently (Fig. 4).  19 
 20 
Obesity and associated disorders are the major noncommunicable public health 21 
problems of the 21st century. Studies indicate that high levels of body fat are associated 22 
with an increased risk of developing numerous adverse health conditions.
19,20)
 Hence, 23 
effective therapeutic approaches to obesity and obesity-induced metabolic syndrome are 24 
of wide interest. In this study, we isolated two furocoumarins and two 25 
polymethoxyflavones from leaves of Casimiroa edulis fruit and evaluated the functions 26 
of glucose and lipids methabolism activation. We found that the addition of 27 
furocoumarins (compounds 1 and 2) caused increased glucose uptake, FA synthesis, and 28 
 10 
lipid accumulation in 3T3-L1 adipocytes. Furanocoumarins are known to have 1 
biological effects in humans. For example, bergamottin and dihydroxybergamottin are 2 
attributable to the grapefruit juice effect, in which these furanocoumarins affect the 3 
metabolism of certain drugs,
21)
 but the concentration of furanocoumarins used in our 4 
assays had no influence on cell viability. They might lower blood glucose levels by 5 
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Figure legends 11 
Fig.1. Structures of Compounds Isolated from Leaves of Casimiroa edulis. 12 
Furocoumarins (compounds 1 and 2), polymethoxyflavones (compounds 3 and 4) 13 
 14 
Fig.2. Mass Spectra of the Isolated Compounds. 15 
     Mass patterns of compounds 1-4 are shown. Compounds 1-2 and Compound 3-4    16 
were analyzed by GC/MS and LC/MS respectively. 17 
  18 
Fig.3. 
13
C6-Glucose Uptake (A), Glycerol Output (B), and De Novo 
13
C-FA Synthesis 19 
(C)  in 3T3-L1 Adipocytes after the Addition of Compounds As Determined by LC/MS 20 
Analysis of the Medium at 48 h. Incubation. 21 
13
C6-Glucose uptake and glycerol output of 3T3-L1 adipocytes after addition of 22 
coumarins and polymethoxyflavones were determined by LC/MS. The concentrations of 23 
13
C6-glucose and glycerol were determined by the LC/MS system at 185 m/z 24 
(
13
C6-glucose) and 91 m/z (glycerol) respectively. De novo synthesis of palmitic acid 25 
was monitored by analyzing 271 (m/z). Lane 1, control; lane 2, pioglitazone; lanes 3-4, 26 
compounds 1 and 2; lanes 5 and 6, compounds 3 and 4 respectively. Lane 1, control; 27 
lane 2, pioglitazone; lanes 3 and 4, compounds 1 and 2; lanes 5 and 6, compounds 3 and 28 
 13 
4 respectively. Concentrations (in M) at all data points is 5.0 **p < 0.05 compared to 1 
control. 2 
 3 
Fig. 4. De Novo 
13
C-FA Synthesis and Lipid Accumulation of 3T3-L1 Adipocytes. 4 
Adipocytes treated with pioglitazone or compounds 1,2 (furocoumarins) (1-100 5 
M) were fixed with 10% formaldehyde/PBS and stained with Oil Red O solution (0.5% 6 
Oil Red O-isopropyl alcohol/H2O 3:2, v/v). Microscopy views of representative 3T3-L1 7 
cells (original magnification, x 100). 8 
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Figure 4, Nagai 
